Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hachimijiogan versus placebo in mild Alzheimer's disease
jRCTs041260016Not yet recruiting
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Alzheimer's disease (AD) comparing Hachimijiogan arm with Placebo arm (2 arms). Primary endpoint: ADAS-Jcog. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
hachimijiogan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCTs041260016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041260016.